Faculty of Medicine news
Stroke victims arriving at Canadian hospitals aren't being treated quickly enough, creating "unacceptable" delays that are increasing the risk of irreversible and devastating brain damage, according to a major new study.
The Montreal Neurological Institute and Hospital – The Neuro, McGill University is committed to providing the highest level of clinical care for ALS patients and their families, as well as state-of-the-art facilities for basic and clinical research.
The Frederick Andermann Fellowship in Epileptology and EEG created in partnership with UCB Pharma, offers both clinical and research training in preparation for a career as an epileptologist.
A year after taking the bold move of distancing itself from most elite medical schools by eliminating the requirement of the Medical College Admission Test, McGill University's medical school says its decision has been staggeringly successful.
One of Canada's leading medical ethicists said provincial funding for experimental medicine is fine, so long as it follows clinical methodology. But a Saint John area doctor said recent provincial funding for a controversial procedure is breaking those ethical guidelines.
Studies in adults have shown weight-loss surgery can cure morbid obesity in adults. McGill University researchers have reported that permanent weight loss via bariatric surgery reduces the risk of death by 89 per cent compared to no surgery in only five years of follow-up.
McGill University’s Faculty of Medicine formalizes its agreement with the Institut de recherches cliniques de Montréal
On June 8, 2011, the Faculty of Medicine and Graduate and Postdoctoral Studies at McGill University presented a formal letter to the Institut de recherches cliniques de Montréal (IRCM), confirming in writing the long-standing arrangement for the supervision of the Faculty’s graduate students at the IRCM. This opportunity will now be extended to postdoctoral education.
Montreal Gazette - Aluminum giant pledges $10M to hospitals; Rio Tinto Alcan rallies business community
Showing the importance of business leadership in building a better - and healthier - community, aluminum-production giant Rio Tinto Alcan announced Wednesday it is donating $10 million to the joint corporate campaigns of Montreal's two new university hospital centres.
Le 31 mai, l'Université McGill a conféré un doctorat honorifique à Rosalind et Morris Goodman, deux Montréalais qui, par l'entremise de la Fondation familiale Goodman, ont mené à bien d'innombrables activités philanthropiques au fil des ans.
The common narrative of positive thinking claims there’s always reason to hope, since hope itself can heal. According to Dr. Amir Raz, it’s difficult to find data to support this.
The Research Institute of the McGill University Health Centre (RI-MUHC) was one of three winners in the Fonds de la recherche en santé du Québec (FRSQ) competition 2011-2012. The RI-MUHC won in the category of Projects for innovative strategic development aimed at supporting projects essential to maintaining the competitiveness of a research centre.
A Joint Message from Principal and Vice-Chancellor Heather Munroe-Blum and MUHC Director-General and CEO, the Hon. Arthur T. Porter
It is with great sadness that we inform you of the passing of Dr. David R. Colman, Director of the Montreal Neurological Institute and Hospital (The Neuro) of McGill University and the McGill University Health Centre, Wilder Penfield Professor of Neuroscience at McGill University and Tier 1 Canada Research Chair in Neuroscience.
Ongoing coverage of a study published last week in the Journal of Neuroscience about a group of pain researchers from McGill University and the McGill University Health Centre found that relieving pain actually causes physical brain changes they can see on a brain scan.
Enlarged prostate: decade-long study demonstrates immediate and long-term benefits of holmium laser treatment
New research presented at the Annual Meeting of the American Urology Association (AUA) in Washington, DC demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia (BPH) – an enlargement of the prostate that affects most men as they age.